How should organisations handle biometric, health, and geolocation data when regulations are getting stricter?

What changes when biometric, health, and geolocation data are treated as high-risk data?

These categories are not ordinary profile attributes. They can reveal who a person is, how they move, and conditions that can affect employment, safety, or discrimination risk. The practical implication is that organisations need tighter justification, stronger access controls, and sharper retention discipline than they would use for standard business data.

The governance question is not just whether the data is useful, but whether the use case is narrow enough to withstand regulatory review. That means separating collection, storage, sharing, and downstream reuse into distinct decisions rather than treating them as one approval.

How should collection and use be constrained?

The safest approach is to start from necessity, not convenience. Collect only what is required for the stated purpose, and make sure the purpose can be defended if a regulator, privacy counsel, or works council asks why a less sensitive alternative would not have been sufficient.

Consent is not a universal fix. Depending on jurisdiction and context, organisations may need a different lawful basis, explicit notices, purpose limitation, and a documented necessity assessment. For geolocation data, that often means being precise about whether continuous tracking is truly required or whether event-based or coarse-location data would achieve the same operational outcome.

Retention should be engineered, not improvised. Sensitive data should have defined expiry, deletion triggers, and exception handling for legal holds or security investigations so that “temporary” collection does not become permanent storage by default.

What controls matter most for storage, access, and oversight?

These data types need strict separation between who collects them, who administers them, and who can actually query them. Access should be role-limited, logged, reviewed, and tied to a clear business purpose, with special care for analytics teams, vendors, and support functions that may request broader access than they need.

Encryption, segregation, and minimised replication are important, but they are not enough on their own. Organisations should also control exports, test environments, and API-driven sharing paths because sensitive data often leaks through secondary systems rather than the primary repository.

Governance should include data mapping, DPIA-style review where applicable, and periodic revalidation when the use case changes. If the data starts being used for monitoring, profiling, fraud detection, or employee management, the original approval may no longer be sufficient.

Risk and Threat Considerations

Biometric, health, and geolocation data create outsized exposure because the harm is not limited to a single account or record. If collected or retained too broadly, they can enable sensitive inferences, workplace misuse, identity-related abuse, or location-based safety concerns, and those consequences tend to persist even after the immediate business purpose ends.

Failure mechanism: Organisations over-collect, reuse, or broadly distribute the data, then lose control through weak access governance, secondary processing, third-party sharing, or retention creep. The risk increases when data is copied into analytics platforms, exported for reporting, or retained beyond the original justification.

Impact: The result can be regulatory action, employee or customer harm, reputational damage, and difficult remediation because sensitive data cannot simply be “unseen” once disclosed. A narrowly scoped use case with strong controls is materially safer than a broad collection model justified only by convenience.

Practitioner Guidance

What to prioritise: Build a defensible inventory first. Practitioners should know exactly where biometric, health, and geolocation data enters the environment, which systems replicate it, and which teams can retrieve it, because that is usually where governance breaks down.

Decision rule: If the same business outcome can be achieved without continuous tracking, persistent biometric storage, or direct health-data handling, treat the less sensitive design as the default. If a sensitive design is still required, require explicit approval, a documented necessity rationale, and a deletion date before production launch.

What to verify: Confirm that access reviews include vendors and service teams, that retention settings are actually enforced in downstream systems, and that consent or notice text matches the real data flow. Gaps often appear not in the policy, but in the handoffs between product, legal, and engineering.

Practitioner takeaway: The key test is whether the organisation can justify each sensitive-data use case as narrowly necessary, continuously controlled, and promptly deletable when the purpose ends.

Related resources from NHI Mgmt Group

• How should organisations handle consent for health data submitted through service portals?
• How should organisations handle biometric data collection in metaverse and VR experiences?
• Why do stricter EU data protection rules increase risk for organisations that handle personal data poorly?
• Why is it important to integrate identity and data governance?